Condition
Total Pancreatectomy
Total Trials
4
Recruiting
0
Active
1
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 1 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Active Not Recruiting1
Completed1
Not Yet Recruiting1
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT07430293Not ApplicableNot Yet Recruiting
Hybrid Closed-Loop Insulin Delivery After Pancreatectomy
NCT06346366Phase 3Active Not Recruiting
Glucose Control Through a Bihormonal Artificial Pancreas in Patients After Total Pancreatectomy
NCT03864744UnknownPrimary
Hepatic Histology and Metabolism Following Total Pancreatectomy and Pancreaticoduodenectomy
NCT03526445Not ApplicableCompleted
Hepatic Metabolic Changes in Response to Glucagon Infusion
Showing all 4 trials